Sandostatin® (octreotide)
(Octreotide) Oncology Oncology
When to use JAKAVI (ruxolitinib)
When to use JAKAVI (ruxolitinib)Use JAKAVI as soon as patients are eligible to bring the most benefit to their lives 1-4 ...
Prescribing JAKAVI (ruxolitinib) for MF
Prescribing JAKAVI (ruxolitinib) for MFJAKAVI is recommended for patients with MF with symptomatic splenomegaly and/or MF-...
Non Hematologic Reactions
JAKAVI (ruxolitinib) safety profile – Non Hematologic ReactionsWell-characterized and manageable...
Hematologic Reactions
JAKAVI (ruxolitinib) safety profile – Hematologic ReactionsHematologic reactions are expected and manageable 1 ...
Starting Dose
Dose adjustment
Trileptal® (oxcarbazepine)
(Oxcarbazepine) Neuroscience PharmaceuticalsEntresto® (sacubitril/valsartan)
Indication Heart Failure Entresto® is indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in adult patients with chronic heart failure. Benefits are most clearly evident in patients with left ventricular ejection...Voltaren® suppositories (Diclofenac Sodium)
(Diclofenac Sodium) Inflammation Pharmaceuticals
×
Ask Speakers
×